Certified Health Limited 12963863 false 2023-08-01 2024-07-31 2024-07-31 The principal activity of the company is Pharmaceuticals Digita Accounts Production Advanced 6.30.9574.0 true true 12963863 2023-08-01 2024-07-31 12963863 2024-07-31 12963863 bus:Director1 2024-07-31 12963863 bus:Director3 2024-07-31 12963863 bus:OrdinaryShareClass1 2024-07-31 12963863 core:CurrentFinancialInstruments 2024-07-31 12963863 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 12963863 core:Non-currentFinancialInstruments core:AfterOneYear 2024-07-31 12963863 core:FurnitureFittingsToolsEquipment 2024-07-31 12963863 bus:SmallEntities 2023-08-01 2024-07-31 12963863 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 12963863 bus:AbridgedAccounts 2023-08-01 2024-07-31 12963863 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 12963863 bus:RegisteredOffice 2023-08-01 2024-07-31 12963863 bus:Director1 2023-08-01 2024-07-31 12963863 bus:Director2 2023-08-01 2024-07-31 12963863 bus:Director3 2023-08-01 2024-07-31 12963863 bus:Director4 2023-08-01 2024-07-31 12963863 bus:OrdinaryShareClass1 2023-08-01 2024-07-31 12963863 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 12963863 core:ComputerEquipment 2023-08-01 2024-07-31 12963863 core:FurnitureFittingsToolsEquipment 2023-08-01 2024-07-31 12963863 countries:England 2023-08-01 2024-07-31 12963863 2023-07-31 12963863 core:FurnitureFittingsToolsEquipment 2023-07-31 12963863 2022-08-01 2023-07-31 12963863 2023-07-31 12963863 bus:OrdinaryShareClass1 2023-07-31 12963863 core:CurrentFinancialInstruments 2023-07-31 12963863 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 12963863 core:Non-currentFinancialInstruments core:AfterOneYear 2023-07-31 12963863 core:FurnitureFittingsToolsEquipment 2023-07-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12963863

Certified Health Limited

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 31 July 2024

 

Certified Health Limited

Directors' Report for the Year Ended 31 July 2024

The directors present their report and the abridged financial statements for the year ended 31 July 2024.

Directors of the company

The directors who held office during the year were as follows:

Mr Bradley Paul McKenny (ceased 21 December 2023)

Mr Matthew Lewis

Mr Peter James Watson (ceased 21 December 2023)

Mr Barnaby Donlon

Principal activity

The principal activity of the company is Pharmaceuticals

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 23 April 2025 and signed on its behalf by:
 

.........................................
Mr Matthew Lewis
Director

.........................................
Mr Barnaby Donlon
Director

 

Certified Health Limited

(Registration number: 12963863)
Abridged Balance Sheet as at 31 July 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

5

1,925

3,687

Current assets

 

Stocks

6

6,758

27,278

Debtors

7

229,918

19,789

Cash at bank and in hand

 

43,801

69,308

 

280,477

116,375

Prepayments and accrued income

 

567

1,034

Creditors: Amounts falling due within one year

(277,936)

(152,718)

Net current assets/(liabilities)

 

3,108

(35,309)

Total assets less current liabilities

 

5,033

(31,622)

Creditors: Amounts falling due after more than one year

(97,222)

-

Accruals and deferred income

 

(3,252)

(1,732)

Net liabilities

 

(95,441)

(33,354)

Capital and reserves

 

Called up share capital

8

100

100

Retained earnings

(95,541)

(33,454)

Shareholders' deficit

 

(95,441)

(33,354)

For the financial year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 23 April 2025 and signed on its behalf by:
 

 

Certified Health Limited

(Registration number: 12963863)
Abridged Balance Sheet as at 31 July 2024

.........................................
Mr Matthew Lewis
Director

.........................................
Mr Barnaby Donlon
Director

 

Certified Health Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
The Globe
Bridge Street
Slaithwaite
HD7 5JH

These financial statements were authorised for issue by the Board on 23 April 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Certified Health Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer and office equipment

33.3% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

 

Certified Health Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2024

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2023 - 5).

4

Loss/profit before tax

Arrived at after charging/(crediting)

2024
£

2023
£

Depreciation expense

3,276

3,088

 

Certified Health Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2024

5

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 August 2023

9,837

9,837

Additions

1,514

1,514

At 31 July 2024

11,351

11,351

Depreciation

At 1 August 2023

6,150

6,150

Charge for the year

3,276

3,276

At 31 July 2024

9,426

9,426

Carrying amount

At 31 July 2024

1,925

1,925

At 31 July 2023

3,687

3,687

6

Stocks

2024
£

2023
£

Other inventories

6,758

27,278

7

Debtors

Debtors includes £Nil (2023 - £Nil) due after more than one year.

8

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100